
Ikarovec
Operator of a gene therapy company intended to treat common eye diseases. The company targets multiple disease targets and pathways that help in targeting multiple disease targets and pathways treatme...
Valuation
$184M
Latest known
Share Price
N/A
Total Raised
$43.9M
Last Round
N/A